secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0000883984-23-000007
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q4 2022 revenue $578M, GAAP net loss $15.5M, provides FY23 guidance
-------------------------------------------------------------------------------

- Revenue $578.0M vs $340.5M YoY; GAAP net loss $(15.5)M ($(0.65)/diluted) vs net income $19.9M ($0.91) in Q4 2021.
- Adjusted diluted EPS $1.60 vs $1.82 YoY; adjusted EBITDA $96.4M vs $64.2M.
- GAAP gross margin 30% vs 37% YoY; gross profit $174.9M vs $127.5M.
- Fiscal year 2023 guidance announced but specific numbers not included in the excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/0000883984-23-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/icui-20230227.htm
  HTML page:      https://secwatch.observer/filing/0000883984-23-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer